Acabal, Danilo .
HRN: 26-20-10 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/11/2024
CLARITHROMYCIN 500MG (CAP)
11/11/2024
11/17/2024
ORAL
500mg
BID
Parapneumonic Process
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes